ロード中...
Somatostatin Receptor 2 signaling promotes growth and tumor survival in Small Cell Lung Cancer
Somatostatin receptor 2 (SSTR2) is overexpressed in a majority of neuroendocrine neoplasms, including small cell lung carcinomas (SCLCs). SSTR2 was previously considered an inhibitory receptor on cell growth, but its agonists had poor clinical responses in multiple clinical trials. The role of this...
保存先:
| 出版年: | Int J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448409/ https://ncbi.nlm.nih.gov/pubmed/30152518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31771 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|